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Influenza and respiratory syncytial virus (RSV) contribute significantly to the burden of acute lower 
respiratory infection (ALRI) inpatient care, but heterogeneous coding practices and availability of 
inpatient data make it difficult to estimate global hospital utilization for either disease based on coded 
diagnoses alone.  
Methods 
This study estimates rates of influenza and RSV hospitalization by calculating the proportion of ALRI due 
to influenza and RSV and applying this proportion to inpatient admissions with ALRI coded as primary 
diagnosis. Proportions of ALRI attributed to influenza and RSV were extracted from a meta-analysis of 
360 total sources describing inpatient hospital admissions which were input to a Bayesian mixed effects 
model over age with random effects over location. Results of this model were applied to inpatient 
admission datasets for 44 countries to produce rates of hospital utilization for influenza and RSV 
respectively, and rates were compared to raw coded admissions for each disease. 
Results 
For most age groups, these methods estimated a higher national admission rate than the rate of directly 
coded influenza or RSV admissions in the same inpatient sources. In many inpatient sources, 
International Classification of Disease (ICD) coding detail was insufficient to estimate RSV burden 
directly. The influenza inpatient burden estimates in older adults appear to be substantially 
underestimated using this method on primary diagnoses alone. Application of the mixed effects model 
reduced heterogeneity between countries in influenza and RSV which was biased by coding practices 





This new method presents the opportunity of estimating hospital utilization rates for influenza and RSV 
using a wide range of clinical databases. Estimates generally seem promising for influenza and RSV 
associated hospitalization, but influenza estimates from primary diagnosis seem highly underestimated 
among older adults. Considerable heterogeneity remains between countries in ALRI coding (i.e., primary 
vs non-primary cause), and in the age profile of proportion positive for influenza and RSV across studies. 
While this analysis is interesting because of its wide data utilization and applicability in locations without 
laboratory-confirmed admission data, understanding the sources of variability and data quality will be 
essential in future applications of these methods.   
Keywords 
Influenza, respiratory syncytial virus, acute lower respiratory infections, inpatient admissions 
Background 
Despite the large burden of lower respiratory infections globally(1), it is difficult to estimate the 
proportion of the hospitalizations attributable to influenza and respiratory syncytial virus (RSV) across 
countries or over time. Heterogeneous coding practices in hospital records across countries limit the 
comparability of administrative datasets from different locations and pose a challenge to producing 
global hospitalization estimates using influenza and RSV-coded inpatient admissions alone. Without the 
addition of laboratory test result data, administrative data may not accurately estimate inpatient 
disease burden, further complicating efforts to model burden at the population level. Absent accurate 
population estimates of the burden of specific respiratory diseases, it will be challenging to conduct 





The Burden of Influenza and RSV Disease (BIRD) project has developed an alternative method that may 
be useful for producing estimates of county-specific influenza and RSV burdens using administrative 
hospitalization data. This method generates rates of influenza and RSV-related acute lower respiratory 
illness (ALRI) hospitalizations across 44 countries by modeling the proportion of ALRI hospitalizations 
specifically attributable to RSV and influenza from literature estimates of laboratory-confirmed influenza 
and RSV among ALRI hospitalizations. The model can be applied to administrative data on country-
specific influenza and RSV utilization. By comparing the results of the BIRD project method to those 
produced by raw extraction of ICD-coded RSV and influenza admission rates, we can estimate the 
potential under-attribution of ALRI to these specific causes. 
Methods 
At a high level, this study estimates influenza and RSV admission rates by modeling the proportion of 
ALRI admissions that are due to influenza and RSV respectively, and then multiplying these proportions 
by ALRI admission rates from clinical administrative data. Figure 1 below is a detailed flowchart of the 
processing steps used in this analysis, and each step is described in further detail in the following 
sections. 





Figure 1 Flowchart of data processing and analysis conducted under this study. This diagram describes processing of ALRI 
admissions from clinical administrative data as well as the modeling and processing performed on RSV and Influenza meta-
analysis proportions. 
ALRI admissions calculation 
We extracted admission counts for ALRI from 29 inpatient all-cause admission datasets covering 44 
countries and containing hospitalizations spanning the years 1990 to 2017, stratified by age in years or 
age groups depending on the source. These datasets included approximately 43 million admissions and 
represent all ICD-coded inpatient admission data used in the Global Burden of Disease Study, an 
international collaborative study led by the Institute for Health Metrics and Evaluation (IHME) at the 
University of Washington and supported by over 4,800 researchers in more than 140 countries(1). 
Additional detail on inpatient data from IHME is listed in Additional File 1. Because only 11 of the 44 
datasets utilized in this study recorded secondary diagnoses, ALRI admissions were defined as those 








ICD-10 J10  Influenza due to identified seasonal influenza virus 
ICD-10 J11  Influenza, virus not identified 
ICD-10 J12  Viral pneumonia, not elsewhere classified 
ICD-10 J13  Pneumonia due to Streptococcus pneumoniae 
ICD-10 J14  Pneumonia due to Haemophilus influenzae 
ICD-10 J15  Bacterial pneumonia, not elsewhere classified 
ICD-10 J16  Pneumonia due to other infectious organisms, not elsewhere classified 
ICD-10 J18  Pneumonia, organism unspecified 
ICD-10 J20  Acute bronchitis 
ICD-10 J21  Acute bronchiolitis 
ICD-10 J22  Unspecified acute lower respiratory infection 
ICD-9 466 Acute bronchitis and bronchiolitis 
ICD-9 480 Viral pneumonia 
ICD-9 481 Pneumococcal pneumonia 
ICD-9 482 Other bacterial pneumonia 
ICD-9 483 Pneumonia due to other specified organism 
ICD-9 484 Pneumonia in infectious diseases classified elsewhere 
ICD-9 485 Bronchopneumonia, organism unspecified 
ICD-9 486 Pneumonia, organism unspecified 
ICD-9 487 Influenza 
ICD-9 488  Influenza due to identified avian influenza virus 
Table 1 ICD codes used to identify ALRI primary admissions.  Note that all more detailed codes below those listed were also 
included. 
The majority of clinical datasets in this analysis contain a subset of the country’s total inpatient 
utilization. For these non-comprehensive clinical sources, counts of ALRI admissions by age were divided 
by the total number of admissions in the dataset to produce age-specific proportions of inpatient 
utilization that have a primary ALRI diagnosis. This proportion is multiplied by IHME’s total inpatient 
utilization envelope to approximate a comprehensive rate of ALRI utilization by age and country. The 
envelope is produced using a spatio-temporal Gaussian process regression that smooths over 
geographic distance and year of hospitalization and that models admission rate per capita by age using 
IHME’s healthcare access quality indicator, supply of inpatient hospital beds, and all-cause mortality as 
predictive covariates. More detail on the envelope estimation process, covariates used in the model and 




The UK Hospital Episode Statistics dataset (2) and Healthcare Cost and Utilization Project National 
Inpatient Sample (HCUP NIS) (3) are considered comprehensive datasets and the scaling described 
above was not applied to these sources. Instead, counts of admissions with a primary ALRI diagnosis in 
these sources were divided by the total population of that country to produce rates of ALRI admission by 
BIRD age group and year. Population estimates are produced as part of IHME’s GBD study and detailed 
information on the methods to produce these estimates are available in related publications(1).   
Most clinical administrative data is provided in age in years or occasionally in various aggregated age 
bins. The age groupings used for the BIRD analysis were at a higher level of aggregation than the 
majority of administrative sources used. Therefore the final step in ALRI admission processing was to 
aggregate rate-space estimates to the BIRD analysis age groups, by summing both the numerator and 
denominator so that the rates of ALRI utilization are binned appropriately to match the rest of the 
analysis. 
While many of the data sources used in this analysis are also used in creating annual GBD estimates, 
there were some differences in data processing methods between the two projects that led to different 
estimates of rates of ALRI. GBD analysis adjusts inpatient data to account for readmissions, potential 
missingness of secondary inpatient diagnoses unavailable outpatient data, and healthcare access and 
quality for every location. It aggregates inpatient data with claims and outpatient data to produce 
estimates of individuals who received any care for an ALRI diagnosis. Because this study was primarily 
focused on inpatient diagnoses of influenza or RSV, these additional corrections were not applied. 
Influenza and RSV proportion estimation 
Influenza and RSV admission rates were estimated by modeling the proportion of admissions for ALRI 
that were attributable to each cause respectively, and then estimating the proportion of total ALRI 




for this model included 156 independent studies on influenza-associated hospitalization rates covering 
46 countries with data between 1979 and 2015 for influenza (4–160), and 204 studies on RSV admission 
rates covering 56 countries with data between 1982 and 2017 (161–365). Sample size of the study, age 
range, and location in study cohort, total admissions for ALRI and admissions for influenza and RSV 
respectively were extracted from each study. The proportion of ALRI admissions due to influenza and 
RSV were calculated for each location, age, and year present in the input study data.  
A Bayesian regularized trimmed meta-regression (MR-BRT) model was generated using ALRI admission 
meta-analysis data to produce estimates of the proportion of ALRI admissions due to each cause while 
accounting for within-study heterogeneity by age and location as well as error and bias between 
sources. Within the MR-BRT framework, the trend over age was modeled as a cubic spline with linear 
tails on the youngest and oldest age groups and an uninformative Gaussian prior. Linear tails on the age 
ends were used to smooth behavior of the age pattern at the poles in cases of sparse data, which can be 
highly unstable in MR-BRT modeling.  
Location was used as a covariate at the IHME Global Burden of Disease’s super-region and regional 
levels, to account for potential geographic variation while informing estimations for locations with 
sparse data by the trend of those with a larger input evidence base. Region was used as a proxy for 
country-level heterogeneity in order to produce estimates where meta-analysis data was available and 
admissions data was not or vice versa. IHME’s regional categorization by country is available in related 
literature(366). Both region and super-region were modeled as a fixed effect with an uninformative 
Gaussian prior on each. The hierarchical structure of the super-regional and regional models results in 
child models that follow the same age trend as those of the parents. 
The equation for the influenza and RSV MR-BRT models is shown in Equation 1 below. Detail on the 




estimation of the posterior using maximum likelihood estimation are available in related literature(367). 
The MR-BRT framework is an R wrapper for the open source mixed effects LimeTr package, which could 
be used to replicate the modeling methods described here(368). 
ln 𝑝(  |  ), , = spline 𝑎𝑔𝑒 , 𝛽 + ln 𝑟𝑒𝑔𝑖𝑜𝑛 , 𝛽 + ln 𝑠𝑢𝑝𝑒𝑟 𝑟𝑒𝑔𝑖𝑜𝑛 , 𝛽 + 𝑍 𝑢 , + 𝜖        (1) 
Where 𝑝(  | ) , ,  is the proportion of ALRI admissions that are positive for flu or RSV in observation i 
for study j, 𝑎𝑔𝑒 ,  is computed using a spline based matrix for age midpoint, 𝑟𝑒𝑔𝑖𝑜𝑛 ,   and 
𝑠𝑢𝑝𝑒𝑟 𝑟𝑒𝑔𝑖𝑜𝑛 ,  are the fixed effects on GBD region and super region, 𝑍 is a linear map, 𝑢 , are the 
random effects from meta-analysis study j at observation i, and 𝜖  are measurement errors with a 
specified covariance. 
 A hierarchical method was chosen a priori for this analysis as it allowed us to produce estimates for 
locations with little or no meta-analysis data while still accounting for location-specific randomness in 
meta-analysis estimates. In the final results of this analysis, location-level estimates maintain age 
heterogeneity based on the differences of age patterns for ALRI admission rates by each location. 
Bootstrapping was performed by taking 1000 samples on the posterior of the MR-BRT model, and 
uncertainty from the samples were propagated through the remainder of the estimation process as 95% 
confidence intervals. 
Final admission rate estimation 
Admission counts and rates for influenza and RSV were calculated by multiplying the proportions from 
the influenza and RSV mixed effects attribution models to annual ALRI admission count estimates by age 
group and location. Seasonality was excluded from the scope of this analysis because seasonal 
information was not consistently available in influenza and RSV meta-analysis literature. Each location 




data for the model existed, in which case an average of the models within the GBD super-region was 
used. Uncertainty was quantified using the upper and lower uncertainty interval from the fit of the 
mixed effects model. Due to meta-analysis data sparsity in older ages for the RSV attribution mixed 
effects model, admission rates and counts for RSV were only calculated for children under five. 
Influenza and RSV-coded primary admissions were extracted from a subset of clinical administrative 
datasets as illustrative scenarios in order to compare results of the BIRD analysis to direct ICD extraction 
with no adjustments. ICD codes used for this comparison can be found in Additional File 2. All locations 
used to illustrate the comparison contained at least 4-digit ICD detail, which was required to identify 
primary admissions for RSV. 
To assess the limitation of using primary diagnosis alone for ALRI admissions, we extracted non-primary 
diagnosis detail from the HCUP NIS data which was used to produce US estimates (3). Diagnosis levels 
available in HCUP NIS vary by state, but all available diagnosis detail up to the 30th inpatient diagnosis 
was included for this analysis. We compared primary and non-primary utilization for the year 2012 from 
this dataset, and applied influenza-attributable proportion estimates to the complete dataset in order to 
generate a comparison of influenza rates that include non-primary hospitalizations. We focused 
specifically on influenza for this sub analysis because of the substantial ALRI utilization as non-primary 
diagnosis in older ages, as there may be competing complications that would end up coded as primary 
discharge diagnosis in this population (369–372). 
Results  
Figures 2 and 3 represent the number of sources of meta-analysis data for the proportion of ALRI 
admissions attributable to influenza and RSV, respectively. Meta-analysis sources varied in their age 
ranges and granularity, sample size and the time range over which studies were conducted. All meta-




Figure 2: Map of Influenza Meta-Analysis Source Data 
 
Figure 2 Influenza meta-analysis data availability by country 
Figure 3: Map of RSV Meta-Analysis Source Data 
 
Figure 3 RSV meta-analysis data availability by country 
Metadata about each of IHME’s inpatient data sources is available in Additional File 1. Only the inpatient 
sources that were ICD-9 or ICD-10 coded were used in this analysis. While all sources listed had 
sufficient ICD detail to extract ALRI utilization rates, not all locations with inpatient admission data have 
at least 4-digit ICD coding which is required to identify RSV cases by ICD diagnosis alone (see Additional 




Figure 4 shows the proportion of ALRI admissions attributable to influenza and RSV at the super-regional 
level. Due to limited meta-data availability in older ages for RSV as seen in the figure, admission rates for 
RSV were only estimated for the under 1 and 1 to 4 year age groups. Data for selected regions are 
tabulated in Table 2 below. 
Figure 4: Proportion of ALRI Admissions Attributable to Influenza and RSV
 
Figure 4 Influenza and RSV proportion models and meta-analysis input data for all IHME super-regions. Data point and model 
line colors reflect the GBD super region. Size of data points is scaled by the standard error of each datum. 
Table 2 Proportion Influenza and RSV positive by GBD Super-Region 
GBD Super Region Age Influenza Positive 
Proportion of ALRI 
Admissions (95% UI) 
RSV Positive 
Proportion of ALRI 




Central Europe, Eastern Europe, and 
Central Asia 
<1 year 0.06 (0.01-0.25) 0.39 (0.14-0.72) 
Central Europe, Eastern Europe, and 
Central Asia 
1 to 4 0.08 (0.01-0.31) 0.24 (0.07-0.55) 
Central Europe, Eastern Europe, and 
Central Asia 
5 to 17 0.22 (0.03-0.63) 0.08 (0.02-0.23) 
Central Europe, Eastern Europe, and 
Central Asia 
18 to 49 0.26 (0.04-0.68) 0.03 (0.01-0.1) 
Central Europe, Eastern Europe, and 
Central Asia 
50 to 64 0.1 (0.01-0.35) 0.01 (0-0.03) 
Central Europe, Eastern Europe, and 
Central Asia 
65 plus 0.02 (0-0.09) 0 (0-0.01) 
High-income <1 year 0.06 (0.01-0.23) 0.36 (0.12-0.68) 
High-income 1 to 4 0.08 (0.01-0.29) 0.22 (0.06-0.51) 
High-income 5 to 17 0.21 (0.03-0.62) 0.07 (0.02-0.2) 
High-income 18 to 49 0.25 (0.04-0.67) 0.03 (0.01-0.08) 
High-income 50 to 64 0.09 (0.01-0.34) 0.01 (0-0.03) 
High-income 65 plus 0.02 (0-0.08) 0 (0-0.01) 
Latin America and Caribbean <1 year 0.05 (0-0.19) 0.43 (0.16-0.76) 
Latin America and Caribbean 1 to 4 0.06 (0.01-0.24) 0.27 (0.08-0.6) 
Latin America and Caribbean 5 to 17 0.18 (0.02-0.56) 0.09 (0.02-0.26) 
Latin America and Caribbean 18 to 49 0.21 (0.03-0.62) 0.03 (0.01-0.11) 
Latin America and Caribbean 50 to 64 0.07 (0.01-0.29) 0.01 (0-0.04) 
Latin America and Caribbean 65 plus 0.01 (0-0.07) 0 (0-0.01) 
North Africa and Middle East <1 year 0.05 (0-0.19) 0.32 (0.1-0.66) 
North Africa and Middle East 1 to 4 0.06 (0.01-0.25) 0.19 (0.05-0.48) 
North Africa and Middle East 5 to 17 0.18 (0.02-0.56) 0.06 (0.01-0.18) 
North Africa and Middle East 18 to 49 0.21 (0.03-0.61) 0.02 (0-0.07) 
North Africa and Middle East 50 to 64 0.07 (0.01-0.29) 0.01 (0-0.03) 
North Africa and Middle East 65 plus 0.02 (0-0.07) 0 (0-0) 
South Asia <1 year 0.04 (0-0.18) 0.33 (0.1-0.67) 
South Asia 1 to 4 0.06 (0.01-0.23) 0.19 (0.05-0.49) 
South Asia 5 to 17 0.17 (0.02-0.54) 0.06 (0.01-0.18) 
South Asia 18 to 49 0.2 (0.03-0.59) 0.02 (0-0.07) 
South Asia 50 to 64 0.07 (0.01-0.27) 0.01 (0-0.03) 
South Asia 65 plus 0.01 (0-0.06) 0 (0-0) 
Southeast Asia, East Asia, and Oceania <1 year 0.08 (0.01-0.29) 0.31 (0.1-0.64) 
Southeast Asia, East Asia, and Oceania 1 to 4 0.1 (0.01-0.36) 0.19 (0.05-0.46) 
Southeast Asia, East Asia, and Oceania 5 to 17 0.26 (0.04-0.68) 0.06 (0.01-0.17) 
Southeast Asia, East Asia, and Oceania 18 to 49 0.3 (0.05-0.73) 0.02 (0-0.07) 
Southeast Asia, East Asia, and Oceania 50 to 64 0.11 (0.01-0.41) 0.01 (0-0.02) 
Southeast Asia, East Asia, and Oceania 65 plus 0.03 (0-0.11) 0 (0-0) 




Sub-Saharan Africa 1 to 4 0.05 (0-0.21) 0.27 (0.08-0.59) 
Sub-Saharan Africa 5 to 17 0.15 (0.02-0.49) 0.09 (0.02-0.26) 
Sub-Saharan Africa 18 to 49 0.18 (0.02-0.55) 0.03 (0.01-0.11) 
Sub-Saharan Africa 50 to 64 0.06 (0.01-0.24) 0.01 (0-0.04) 
Sub-Saharan Africa 65 plus 0.01 (0-0.06) 0 (0-0.01) 
 
Table 2 Proportion of ALRI admissions that are influenza and RSV positive for all IHME super-regions stratified by BIRD age 
group. 
In these results, influenza represents a significant proportion of ALRI admissions in individuals aged 15 
to 55 years, and a lower proportion in the oldest and youngest age groups. Conversely, RSV represents 
over 30% of all ALRI admissions for infants under 1 year and over 18% for infants aged 1-4, but the 
proportion of ALRI admissions attributable to RSV drops dramatically in age groups beyond the age of 5 
years.  
Comparisons of admission rates calculated through the BIRD analysis versus those coded directly with 
influenza and RSV ICD codes for locations with sufficient ICD granularity are shown in Figures 5 and 6, 
and tabulated in Tables 3 and 4. For almost all age groups, the methods as described in this paper 
estimated a higher national admission rate than the rate of directly coded influenza or RSV admissions in 
the same inpatient sources. Many inpatient data sources used at IHME are coded only to three or four 
digits, in which case it is less accurate or even not possible to estimate RSV admission rates. Detail on 
inpatient clinical sources and ICD granularity is listed in Additional File 1, and the ICD codes used to 
determine influenza and RSV inpatient admissions are listed in Additional File 2. The full dataset of BIRD 




Figure 5: Influenza Admission Rate by BIRD Analysis and ICD Coding 
 
Figure 5 Influenza admission rate per 100,000 people by age as produced by BIRD analysis (blue) and simple raw ICD code 
extraction (yellow). 95% CI shown for both estimates. 
Table 3 Influenza rates by BIRD analysis and ICD code extraction for select locations 
Country Age Group BIRD Rate per 100,000 
(95% UI) 
ICD-Coded Rate per 100,000 (95% 
UI) 
Ecuador <1 year 64.5 (6 - 260.9) 9.8 (9.1 - 10.6) 
Ecuador 1 to 4 56.5 (4.3 - 210) 5.5 (5.2 - 5.8) 
Ecuador 5 to 17 22.1 (2.2 - 75.5) 1.5 (1.4 - 1.6) 
Ecuador 18 to 49 12.8 (1.7 - 39.6) 1.8 (1.7 - 1.8) 
Ecuador 50 to 64 10 (1 - 39.1) 2.4 (2.2 - 2.6) 




Georgia <1 year 50.3 (6.5 - 375.9) 16.2 (9.7 - 22.7) 
Georgia 1 to 4 54 (7.3 - 385.5) 22.5 (18.8 - 26.1) 
Georgia 5 to 17 46.2 (8 - 219.6) 6.8 (5.6 - 8) 
Georgia 18 to 49 23.5 (4 - 87.6) 2.8 (2.4 - 3.3) 
Georgia 50 to 64 19.8 (2.4 - 107.2) 2.8 (2.1 - 3.5) 
Georgia 65 plus 7.9 (0.9 - 64.8) 2.8 (2 - 3.6) 
India <1 year 11.1 (1 - 46.4) 0.6 (0.6 - 0.7) 
India 1 to 4 14.9 (1.5 - 59.8) 1.1 (1.1 - 1.1) 
India 5 to 17 10.5 (1.2 - 35.1) 0.2 (0.2 - 0.2) 
India 18 to 49 16.6 (2 - 47.7) 3.7 (3.7 - 3.7) 
India 50 to 64 10.2 (1 - 40.8) 3.8 (3.7 - 3.8) 
India 65 plus 5.9 (0.5 - 25.4) 3.9 (3.8 - 3.9) 
Mexico <1 year 98.4 (10.3 - 458.1) 4.3 (4.1 - 4.5) 
Mexico 1 to 4 87 (9.3 - 388.3) 7.1 (7 - 7.2) 
Mexico 5 to 17 22.8 (3 - 74) 1.9 (1.9 - 2) 
Mexico 18 to 49 6.6 (0.9 - 21.6) 0.8 (0.8 - 0.8) 
Mexico 50 to 64 8.4 (0.9 - 33.2) 1.5 (1.4 - 1.5) 
Mexico 65 plus 7.3 (0.7 - 32.7) 1.3 (1.2 - 1.4) 
New Zealand <1 year 58 (6 - 231.5) 15.7 (13.3 - 18.1) 
New Zealand 1 to 4 131.6 (13.6 - 482.9) 46.7 (44.6 - 48.8) 
New Zealand 5 to 17 18.1 (2.7 - 54) 5.7 (5.3 - 6.1) 
New Zealand 18 to 49 25.4 (3.8 - 66.7) 5.7 (5.5 - 6) 
New Zealand 50 to 64 13.6 (1.5 - 50.1) 5.5 (5.1 - 5.9) 
New Zealand 65 plus 11.3 (1 - 50.2) 10.5 (9.8 - 11.2) 
Philippines <1 year 104.4 (11.4 - 394.8) 11.6 (10.7 - 12.5) 
Philippines 1 to 4 288.2 (32.6 - 1024) 53.7 (52.6 - 54.7) 
Philippines 5 to 17 390.7 (60.8 - 1007.2) 66.2 (65.5 - 66.8) 
Philippines 18 to 49 110.6 (18.8 - 267.5) 16.3 (16 - 16.6) 
Philippines 50 to 64 91.4 (10.7 - 310.1) 14.5 (14 - 15) 
Philippines 65 plus 42.5 (3.9 - 179.1) 12.3 (11.6 - 13.1) 
Sweden <1 year 128.5 (11.1 - 523.3) 25.2 (22.8 - 27.7) 
Sweden 1 to 4 60.1 (6.9 - 294.4) 22.3 (21.2 - 23.5) 
Sweden 5 to 17 11.6 (1.8 - 82.7) 4.8 (4.5 - 5.1) 
Sweden 18 to 49 12 (2.1 - 63.8) 3.5 (3.3 - 3.6) 
Sweden 50 to 64 5.5 (0.7 - 41.9) 5.9 (5.6 - 6.2) 
Sweden 65 plus 5.8 (0.6 - 41.7) 16.9 (16.2 - 17.5) 
Turkey <1 year 50.8 (4.9 - 205.6) 1.3 (0.8 - 1.8) 
Turkey 1 to 4 284.7 (28 - 1137) 8.4 (7.8 - 9) 
Turkey 5 to 17 130.3 (16.5 - 400.1) 2.2 (2.1 - 2.4) 
Turkey 18 to 49 28.9 (4.1 - 83.5) 2.3 (2.2 - 2.4) 
Turkey 50 to 64 23.2 (2.4 - 90.7) 2.6 (2.4 - 2.8) 






<1 year 168.4 (16.2 - 714.1) 139.5 (138.4 - 140.7) 
United States 
of America 
1 to 4 43.4 (4.4 - 175.8) 36.1 (35.8 - 36.4) 
United States 
of America 
5 to 17 16.6 (2.3 - 54.5) 7.2 (7.1 - 7.3) 
United States 
of America 
18 to 49 27.8 (4.1 - 80.9) 4.8 (4.8 - 4.8) 
United States 
of America 
50 to 64 31.6 (3.4 - 122.6) 9.6 (9.5 - 9.6) 
United States 
of America 
65 plus 27 (2.5 - 122.6) 32 (31.8 - 32.2) 
Table 3 BIRD estimates of rates of influenza admission as compared to the rate from a raw ICD code extraction. BIRD and raw 




Figure 6: RSV Admission Rate by BIRD Analysis and ICD Coding 
 
Figure 6 RSV admission rate per 100,000 by age as produced by BIRD analysis (blue) and simple raw ICD code extraction 
(yellow). 95% CI shown for both estimates. 
Table 4 RSV rates by BIRD analysis and ICD code extraction for select locations 
Country Age Group BIRD Rate per 100,000 (95% 
UI) 
ICD-Coded Rate per 
100,000 (95% UI) 
Ecuador <1 year 525.9 (154.2 - 1069.9) 0.1 (0 - 0.1) 
Ecuador 1 to 4 216.4 (40.5 - 508.3) 0 (0 - 0) 




Georgia 1 to 4 102.9 (28.6 - 595.6) 0 (0 - 0.5) 
India <1 year 83.4 (23.3 - 184.1) 0 (0 - 0) 
India 1 to 4 50.3 (12.1 - 127.4) 0 (0 - 0) 
Mexico <1 year 865.6 (306.8 - 2077.7) 8.8 (8.4 - 9.1) 
Mexico 1 to 4 364.3 (101.4 - 992.8) 3.2 (3.1 - 3.3) 
New Zealand <1 year 318.3 (100.4 - 646.3) 163.3 (155.6 - 171) 
New Zealand 1 to 4 327.7 (82.2 - 781.2) 89.4 (86.5 - 92.2) 
Philippines <1 year 429.4 (135.6 - 876.1) 0.1 (0 - 0.2) 
Philippines 1 to 4 536.1 (138.8 - 1306.9) 0.1 (0 - 0.1) 
Sweden <1 year 750.8 (184 - 1744.6) 758.7 (746.1 - 771.3) 
Sweden 1 to 4 160.8 (43.1 - 581.1) 62 (60.2 - 63.9) 
Turkey <1 year 347.8 (107 - 711.8) 0.4 (0.1 - 0.7) 
Turkey 1 to 4 875 (224.2 - 2177) 1.5 (1.2 - 1.7) 
United States of 
America 
<1 year 1623.6 (595.2 - 3201.2) 1557 (1553.2 - 1560.8) 
United States of 
America 
1 to 4 209.2 (61.6 - 469.9) 118.4 (117.9 - 118.9) 
Table 4 BIRD estimates of rates of RSV admission as compared to the rate from a raw ICD code extraction. BIRD and raw coded 
rate are produced across all years of available data for each country. 
As non-primary diagnoses were not available for the majority of sources of inpatient admission data, 
only primary diagnosis was used to expand the number of useable sources and retain consistency across 
locations. We conducted a sensitivity analysis comparing the average primary and non-primary 
admission rates for ALRI in the United States from 2002 to 2012 to illustrate the potential impact of 
limiting the analysis to ALRI as primary diagnosis only. 
Influenza admission rates in the US by primary-only diagnosis and primary and non-primary diagnosis 




for children <1 year, and nearly a 2.5-fold increase in rates estimated in the 18-49, 50 to 64, and 65 plus 
age groups. 
Figure 7: Primary versus Nonprimary Influenza Admission Rate in the US, 2012 
 
Figure 7 Influenza admission rate by diagnosis position, in US HCUP NIS data. Uncertainty is capped in order to show estimated 
age pattern. 
Discussion 
While influenza and RSV associated healthcare utilization is acknowledged as a global problem, gaps in 
quantifying the magnitude of this problem exist due to lack in representative data availability across 
locations that makes assessing admission rates within or across countries challenging. Traditional 
methods of burden estimation based on laboratory-confirmed cases are not possible in most settings 
because testing patients with ALRI is not routine care. This analysis utilizes clinical administrative data 




more robust than direct ICD extraction alone. The approach, however, has important limitations for 
influenza when considering older adults. 
While the true burden of RSV in children is unknown, estimates of RSV admission rates from this study 
are generally consistent with published literature on RSV hospital utilization in children under 5. Shi et al 
estimate hospital admission rates of 26.3 (22.8 – 30.2) per 1000 in children aged 1-5 months, 11.3 (6.1 – 
20.9) per 1000 in children 6-11 months, and 1.4 (0.9 – 2.0) per 1000 in children 12-59 months old in 
World Bank High Income countries(373). Reeves et al found admission rates for RSV of 35.1 (32.9 – 38.9) 
per 1000 in children under 1 year and 5.31 (4.46 – 6.59) per 1000 in children age 1-4 years old in 
England(374). Estimates from the BIRD analysis as shown in Table 4 are lower in high income settings for 
children under 1 year of age than either study, but fall between estimates of older children as described 
in the literature. Further discussion and comparisons of the results of the BIRD analysis for RSV to other 
RSV estimation methods are available in related literature(375). 
Our estimated admission rates for influenza are generally an underestimate of rates previously 
published, particularly in the 65+ age group(376–378). For the United States and Sweden at age 65+, the 
simple extracted ICD-coded admission rate from administrative datasets surpasses the rate produced by 
this study. The inclusion of non-primary diagnoses did increase estimates for influenza in the US by more 
than 50%. Nonetheless, these rates are still lower than those produced by comparable studies in the 
oldest age group. Previous studies estimate that anywhere between 39.5% and 96.6% of all admissions 
across all ages for influenza have a primary diagnosis related to influenza, and the relative proportion of 
burden as a primary diagnosis in this analysis fall within that range(369–372). While using only the 
primary diagnosis allowed us to maintain consistency with the 33 sources containing only primary 
diagnostic detail, future iterations of this method should consider inclusion of non-primary diagnoses for 




Estimates of the proportion of influenza-positive adults age 65+ were also generally lower than existing 
literature. Jain et al estimate that 4% adults aged 65-79 years and 5% adults 80 or older hospitalized for 
pneumonia in select US cities test positive for influenza(32). Monto et al report 10.9% of adults aged 50 
or older presenting with acute respiratory illness are influenza positive, in a study of families in Ann 
Arbor Michigan over 3 years(69). Our analysis estimates 1.9% (0.02 - 8.4) of ALRI admissions in ages 65+ 
in IHME high-income settings are influenza positive cases. While the upper bound of this estimate more 
closely aligns with existing published literature, the proportion positive estimated from the BIRD project 
is low because of data sparsity in oldest ages. The age spline method used in the MR-BRT analysis 
depends on age midpoint of meta-analysis input data instead of accounting for an age range, which 
narrows the number of estimates representing older ages. Inclusion of additional meta-analysis data and 
incorporation of more sophisticated age range splitting could produce more robust proportion estimates 
in older ages.  
The methodology employed by this analysis is comparable to previous burden estimates for influenza 
produced by IHME in the application of a proportion model to estimates of total lower respiratory 
infection(379). However, estimates from the BIRD project were formed using a categorical approach 
that did not account for the relative risk of ALRI in cases of confirmed influenza or RSV. Instead, the 
proportion of ALRI hospitalizations was assumed to be a proxy of total utilization. Additionally, the BIRD 
analysis focuses exclusively on inpatient hospital utilization instead of incidence or mortality, which 
reduced the assumptions made about how trends in utilization can be extended to other metrics. 
Finally, the hierarchical method of modeling proportion positive by region and super-region was a novel 
approach used in burden analysis to allow for estimates in locations with sparser meta-analysis data to 
have more robust proportion estimates over age. IHME’s GBD global influenza admission rate estimates 




(CI: 48.5-300.2) across all ages as compared to BIRD all-age rates of 29.7 per 100,000 (CI: 3.64-101.7) in 
the US to 195.81 (183.88-207.74) in the Philippines. 
This study met limitations that are consistent with any analysis developed from clinical administrative 
data. Availability of inpatient admissions data in some lower- to middle- income countries and meta-
analysis data for RSV in older children and adults limited the scope of this analysis, and additional 
sources of both types of data would improve accuracy of estimates. Availability of inpatient data and 
proportion meta-analysis at a seasonal or monthly granularity would allow for more relevant analysis 
during peak influenza and RSV seasons. Additionally, we encountered technical limitations in handling of 
meta-analysis with point estimates for proportion positive spanning large age ranges, and in the 
assumption made that influenza and RSV proportions across countries will follow the same pattern over 
age. Finally, the rates estimated in this analysis represent utilization rates of influenza and RSV present 
in individuals who have a primary admission diagnosis of acute lower respiratory infection. Accounting 
for non-inpatient care including urgent or emergency departments, and adjustments for non-primary 
diagnosis when ALRI is not the primary reason for visit would further improve the estimates produced 
by this analysis.  
In addition to addressing the limitations described, future iterations of this methodology could be 
expanded to estimates of incidence or prevalence from utilization by accounting for health care access 
and care-seeking behavior. Furthermore, deeper investigation of goodness-of-fit of the proportion 
models through out of sample estimation would provide additional validation for the methods proposed 
here and potentially identify additional areas for refinement of the proportion models. 
Conclusions 
Because of heterogeneity in coding practices between countries and limited availability of data at 




hospital utilization or incidence that are provided on a global scale. The application of meta-analysis for 
proportion positive to overall ALRI utilization is a non-traditional means of estimation that indicate 
promise in other applications where direct measurement of ICD diagnoses cannot provide accurate 
estimates of rates of disease and where surveillance data are not available. However, the method shows 
much uncertainty when considering influenza in older adults that could be a function of considerable 
heterogeneity in ALRI coding between countries (i.e., as primary vs secondary cause), and in the age 
profile of proportion positivity for influenza and RSV across studies. While this method is interesting 
because it is based on clinical administrative data that is available from many countries globally, 
additional refinement of admission processing methodology and inclusion of more data over ages would 
enable greater comparability to existing influenza and RSV utilization literature. 
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Figure Legends 




Figure 1 Flowchart of data processing and analysis conducted under this study. This diagram describes processing of ALRI 
admissions from clinical administrative data as well as the modeling and processing performed on RSV and Influenza meta-
analysis proportions. 
Figure 2: Map of Influenza Meta-Analysis Source Data 
Figure 2 Influenza meta-analysis data availability by country 
Figure 3: Map of RSV Meta-Analysis Source Data 
Figure 3 RSV meta-analysis data availability by country 
Figure 4: Proportion of ALRI Admissions Attributable to Influenza and RSV 
Figure 4 Influenza and RSV proportion models and meta-analysis input data for all IHME super-regions. Data point and model 
line colors reflect the GBD super region. Size of data points is scaled by the standard error of each datum.  
Figure 5: Influenza Admission Rate by BIRD Analysis and ICD Coding 
Figure 5 Influenza admission rate per 100,000 people by age as produced by BIRD analysis (blue) and simple raw ICD code 
extraction (yellow). 95% CI shown for both estimates. 
Figure 6: RSV Admission Rate by BIRD Analysis and ICD Coding 
Figure 6 RSV admission rate per 100,000 by age as produced by BIRD analysis (blue) and simple raw ICD code extraction 
(yellow). 95% CI shown for both estimates. 
Figure 7: Primary versus Nonprimary Influenza Admission Rate in the US, 2012 
Figure 7 Influenza admission rate by diagnosis position, in US HCUP NIS data. Uncertainty is capped in order to show estimated 
age pattern. 
Table 1 






Table 2 Proportion of ALRI admissions that are influenza and RSV positive for all IHME super-regions stratified by BIRD age 
group. 
Table 3 
Table 3 BIRD estimates of rates of influenza admission as compared to the rate from a raw ICD code extraction. BIRD and raw 
coded rate are produced across all years of available data for each country. 
Table 4 
Table 4 BIRD estimates of rates of RSV admission as compared to the rate from a raw ICD code extraction. BIRD and raw coded 
rate are produced across all years of available data for each country. 
